TY  - GEN
AU  - Kruis,W
AU  - Schreiber,S
AU  - Theuer,D
AU  - Brandes,J W
AU  - Schütz,E
AU  - Howaldt,S
AU  - Krakamp,B
AU  - Hämling,J
AU  - Mönnikes,H
AU  - Koop,I
AU  - Stolte,M
AU  - Pallant,D
AU  - Ewald,U
TI  - Low dose balsalazide (1.5 g twice daily) and mesalazine (0.5 g three times daily) maintained remission of ulcerative colitis but high dose balsalazide (3.0 g twice daily) was superior in preventing relapses
SN  - 0017-5749
PY  - 2001///1228
KW  - Aminosalicylic Acids
KW  - administration & dosage
KW  - Anti-Inflammatory Agents, Non-Steroidal
KW  - Colitis, Ulcerative
KW  - drug therapy
KW  - Colon
KW  - pathology
KW  - Double-Blind Method
KW  - Drug Administration Schedule
KW  - Female
KW  - Humans
KW  - Male
KW  - Mesalamine
KW  - Phenylhydrazines
KW  - Prodrugs
N1  - Publication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1136/gut.49.6.783
ER  -